BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27733215)

  • 1. ZNRF3 Inhibits the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Cells by Inactivating the Wnt/β-Catenin Pathway.
    Wang Z; Wang Y; Ren H; Jin Y; Guo Y
    Oncol Res; 2017 Apr; 25(4):571-577. PubMed ID: 27733215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.
    Zhang J; Wen X; Ren XY; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Sun Y; Liu N; Ma J
    J Exp Clin Cancer Res; 2016 Jul; 35(1):109. PubMed ID: 27400785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RSPO2 silence inhibits tumorigenesis of nasopharyngeal carcinoma by ZNRF3/Hedgehog-Gli1 signal pathway.
    Wang Z; Wang Y; Ma X; Dang C
    Life Sci; 2021 Oct; 282():119817. PubMed ID: 34273374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway.
    Zhang Y; Zhang H; Li X
    J BUON; 2020; 25(3):1579-1586. PubMed ID: 32862607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of TMPRSS3, a Transmembrane Serine Protease, Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.
    Wang JY; Jin X; Li XF
    Oncol Res; 2018 Jan; 26(1):95-101. PubMed ID: 28409556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZNF488 Enhances the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Via the Wnt Signaling Pathway Involving Epithelial Mesenchymal Transition.
    Zong D; Yin L; Zhong Q; Guo WJ; Xu JH; Jiang N; Lin ZR; Li MZ; Han P; Xu L; He X; Zeng MS
    Cancer Res Treat; 2016 Jan; 48(1):334-44. PubMed ID: 25779368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
    Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
    Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
    Zhang T; Yin P; Zhang Z; Xu B; Che D; Dai Z; Dong C; Jiang P; Hong H; Yang Z; Zhou T; Shao J; Xu Z; Yang X; Gao G
    Cell Death Dis; 2017 Jun; 8(6):e2838. PubMed ID: 28569772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
    Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
    Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
    Qiu W; Yang Z; Fan Y; Zheng Q
    Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.
    Chen C; Lu Z; Yang J; Hao W; Qin Y; Wang H; Xie C; Xie R
    Cancer Med; 2016 Dec; 5(12):3489-3499. PubMed ID: 27774777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
    Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
    Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX1 down-regulates β-catenin and reverses malignant phenotype in nasopharyngeal carcinoma.
    Guan Z; Zhang J; Wang J; Wang H; Zheng F; Peng J; Xu Y; Yan M; Liu B; Cui B; Huang Y; Liu Q
    Mol Cancer; 2014 Nov; 13():257. PubMed ID: 25427424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma.
    Chen T; Long B; Ren G; Xiang T; Li L; Wang Z; He Y; Zeng Q; Hong S; Hu G
    J Cell Biochem; 2015 Aug; 116(8):1766-75. PubMed ID: 25736877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma.
    Zou G; Ren B; Liu Y; Fu Y; Chen P; Li X; Luo S; He J; Gao G; Zeng Z; Xiong W; Li G; Huang Y; Xu K; Zhang W
    Cancer Sci; 2018 Nov; 109(11):3416-3427. PubMed ID: 30151927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
    Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
    Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.
    Liu ZF; Yang J; Wei SP; Luo XG; Jiang QS; Chen T; Gong YQ
    Kaohsiung J Med Sci; 2020 Nov; 36(11):895-903. PubMed ID: 32668092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B; Wang Y; Yin F
    Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.